The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms

Cancer

Volumn 118, Issue 10, 2012, Pages 2763-2775

  Schimmack, Simon ^a,b   Lawrence, Ben ^a   Svejda, Bernhard ^a   Alaimo, Daniele ^a   Schmitz Winnenthal, Hubertus ^b   Fischer, Lars ^b   Büchler, Markus W ^b   Kidd, Mark ^a   Modlin, Irvin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

biomarker; BON pancreatic cell line; carcinoids; internexin alpha; Ki 67; metastasis; neuroendocrine neoplasm; neurofilament; pancreatic neuroendocrine tumor

Indexed keywords

ALPHA INTERNEXIN; CHROMOGRANIN A; KI 67 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROFILAMENT L PROTEIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROCHROMAFFIN CELL; ENZYME INHIBITION; GASTROENTEROPANCREATIC NEUROENDOCRINE CANCER; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNEXIN ALPHA GENE; METASTASIS; MOUSE; NEUROFILAMENT L GENE; NEUROFILAMENT M GENE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CELL; PANCREATIC NEUROENDOCRINE TUMOR; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SMALL INTESTINE CANCER; SMALL INTESTINE MUCOSA; TUMOR GENE; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; GASTROINTESTINAL NEOPLASMS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MICE; NEUROENDOCRINE TUMORS; NEUROFILAMENT PROTEINS; PANCREAS; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84860667554     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26592     Document Type: Article

References (45)

1. Calender A,. Molecular genetics of neuroendocrine tumors. Digestion. 2000; 62 (suppl 1): 3-18.
2. Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008; 9: 61-72.
3. Schimmack S, Svejda B, Lawrence B, Kidd M, Modlin IM,. The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors. Langenbecks Arch Surg. 2011; 396: 273-298.
4. Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M,. Chromogranin A-biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol. 2010; 17: 2427-2443.
5. Vogelsang H, Siewert JR,. Endocrine tumours of the hindgut. Best Pract Res Clin Gastroenterol. 2005; 19: 739-751.
6. Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007; 451: 757-762.
7. Kloppel G, Couvelard A, Perren A, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology. 2009; 90: 162-166.
8. La Rosa S, Sessa F, Capella C, et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 1996; 429: 323-333.
9. Van Eeden S, Quaedvlieg PF, Taal BG, Offerhaus GJ, Lamers CB, Van Velthuysen ML,. Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol. 2002; 33: 1126-1132.
10. Panzuto F, Nasoni S, Falconi M, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer. 2005; 12: 1083-1092.
11. Gestblom C, Hoehner JC, Hedborg F, Sandstedt B, Pahlman S,. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas. Am J Pathol. 1997; 150: 107-117.
12. Tapia FJ, Polak JM, Barbosa AJ, et al. Neuron-specific enolase is produced by neuroendocrine tumours. Lancet. 1981; 1: 808-811.
13. Wiedenmann B, Waldherr R, Buhr H, Hille A, Rosa P, Huttner WB,. Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin A, secretogranin I (chromogranin B), and secretogranin II. Gastroenterology. 1988; 95: 1364-1374.
14. Paramio JM, editor. Intermediate Filaments. New York: Landes Bioscience, Springer Science, and Business Media, LLC; 2006.
15. Kidd M, Modlin IM, Mane SM, Camp RL, Eick G, Latich I,. The role of genetic markers-NAP1L1, MAGE-D2, and MTA1-in defining small-intestinal carcinoid neoplasia. Ann Surg Oncol. 2006; 13: 253-262.
16. Drozdov I, Tsoka S, Ouzounis CA, Shah AM,. Genome-wide expression patterns in physiological cardiac hypertrophy [serial online]. BMC Genomics. 2010; 11: 557.
17. Duprey P, Paulin D,. What can be learned from intermediate filament gene regulation in the mouse embryo? Int J Dev Biol. 1995; 39: 443-457.
18. Kaplan MP, Chin SS, Fliegner KH, Liem RK,. Alpha-internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain. J Neurosci. 1990; 10: 2735-2748.
19. Rauch U, Klotz M, Maas-Omlor S, et al. Expression of intermediate filament proteins and neuronal markers in the human fetal gut. J Histochem Cytochem. 2006; 54: 39-46.
20. Foley J, Witte D, Chiu FC, Parysek LM,. Expression of the neural intermediate filament proteins peripherin and neurofilament-66/alpha-internexin in neuroblastoma. Lab Invest. 1994; 71: 193-199.
21. Willoughby V, Sonawala A, Werlang-Perurena A, Donner LR,. A comparative immunohistochemical analysis of small round cell tumors of childhood: utility of peripherin and alpha-internexin as markers for neuroblastomas. Appl Immunohistochem Mol Morphol. 2008; 16: 344-348.
22. Kaya B, Mena H, Miettinen M, Rushing EJ,. Alpha-internexin expression in medulloblastomas and atypical teratoid-rhabdoid tumors. Clin Neuropathol. 2003; 22: 215-221.
23. Ducray F, Mokhtari K, Criniere E, et al. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas. Eur J Cancer. 2011; 47: 802-808.
24. Mokhtari K, Ducray F, Kros JM, et al. Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European Organization for Research and Treatment of Cancer Trial 26951. Cancer. 2011; 117: 3014-3026.
25. Arnold R, Rinke A, Klose KJ, et al. Octreotide versus octreotide plus interferon-alpha in endocrine gastroenteropancreatic tumors: a randomized trial. Clin Gastroenterol Hepatol. 2005; 3: 761-771.
26. Pfragner R, Behmel A, Hoger H, et al. Establishment and characterization of 3 novel cell lines-P-STS, L-STS, H-STS-derived from a human metastatic midgut carcinoid. Anticancer Res. 2009; 29: 1951-1961.
27. Siddique ZL, Drozdov I, Floch J, et al. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model. Neuroendocrinology. 2009; 89: 458-470.
28. Kidd M, Modlin IM, Pfragner R, et al. Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor-beta1-mediated regulatory abnormalities including up-regulation of C-Myc and MTA1. Cancer. 2007; 109: 2420-2431.
29. Svejda B, Kidd M, Kazberouk A, Lawrence B, Pfragner R, Modlin IM,. Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor-mediated PI3K feedback loop activation via ERK1/2 and AKT. Cancer. 2011; 117: 4141-4154.
30. Kidd M, Eick G, Shapiro MD, Camp RL, Mane SM, Modlin IM,. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors. Cancer. 2005; 103: 229-236.
31. Kidd M, Nadler B, Mane S, et al. GeneChip, geNorm, and gastrointestinal tumors: novel reference genes for real-time PCR. Physiol Genomics. 2007; 30: 363-370.
32. Kidd M, Modlin IM, Mane SM, Camp RL, Shapiro MD,. Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease. Ann Surg. 2006; 243: 273-280.
33. Karhoff D, Sauer S, Schrader J, et al. Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target. Neuroendocrinology. 2007; 85: 45-53.
34. Pitt SC, Chen H, Kunnimalaiyaan M,. Inhibition of phosphatidylinositol 3-kinase/Akt signaling suppresses tumor cell proliferation and neuroendocrine marker expression in GI carcinoid tumors. Ann Surg Oncol. 2009; 16: 2936-2942.
35. Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E,. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst. 2008; 100: 1282-1289.
36. Yang Z, Tang LH, Klimstra DS,. Effect of tumor heterogeneity on the assessment of Ki-67 labeling index in well differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am J Surg Pathol. 2011; 35: 853-860.
37. Ducray F, Idbaih A, de Reynies A, et al. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile [serial online]. Mol Cancer. 2008; 7: 41.
38. Novelli MR, Williamson JA, Tomlinson IP, et al. Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science. 1996; 272: 1187-1190.
39. Taylor RW, Barron MJ, Borthwick GM, et al. Mitochondrial DNA mutations in human colonic crypt stem cells. J Clin Invest. 2003; 112: 1351-1360.
40. Greaves LC, Preston SL, Tadrous PJ, et al. Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proc Natl Acad Sci U S A. 2006; 103: 714-719.
41. McDonald SA, Greaves LC, Gutierrez-Gonzalez L, et al. Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology. 2008; 134: 500-510.
42. Bouwens L, Kloppel G,. Islet cell neogenesis in the pancreas. Virchows Arch. 1996; 427: 553-560.
43. Paris M, Tourrel-Cuzin C, Plachot C, Ktorza A,. Review: pancreatic beta-cell neogenesis revisited. Exp Diabesity Res. 2004; 5: 111-121.
44. Lawrence B, Gustafsson BI, Chan A, Svejda B, Kidd M, Modlin IM,. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011; 40: 1-18, vii.
45. Liem RK,. Molecular biology of neuronal intermediate filaments. Curr Opin Cell Biol. 1993; 5: 12-16.